1.
Yosef B, Kaddar N, Boubou A. Evaluation of the Effect of Dapagliflozin on CRP Levels in Type 2 Diabetes Patients. Jordan j. pharm. sci. [Internet]. 2023 Jun. 25 [cited 2024 Jul. 5];16(2):313-21. Available from: http://jjournals.ju.edu.jo/index.php/jjps/article/view/1331